Advisornet Financial’s Dr. Reddy's Laboratories RDY Stock Holding History

Advisornet Financial’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40	Closed	-$562	–	2343
2025 Q4	$562	Hold	40	–	–	﹤0.01%	2076
2025 Q3	$559	Hold	40	–	–	﹤0.01%	2054
2025 Q2	$601	Hold	40	–	–	﹤0.01%	2025
2025 Q1	$528	Hold	40	–	–	﹤0.01%	1961
2024 Q4	$632	Hold	40	–	–	﹤0.01%	1730
2024 Q3	$636	Hold	40	–	–	﹤0.01%	2001
2024 Q2	$610	Hold	40	–	–	﹤0.01%	1914
2024 Q1	$587	Hold	40	–	–	﹤0.01%	1868
2023 Q4	$557	Buy	+40	New	+$535	﹤0.01%	2070
2022 Q3	–	Sell	-270	Closed	-$3K	–	2012
2022 Q2	$3K	Hold	270	–	–	﹤0.01%	1638
2022 Q1	$3K	Buy	+270	New	+$3.06K	﹤0.01%	1743

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Advisornet Financial's RDY Position: Q1 2026 in Review

Advisornet Financial sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 40 shares — an estimated $562 sold.

Advisornet Financial first reported a position in RDY in Q1 2022 and held it in 11 quarters. The position peaked at $3K in Q2 2022. 249 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

Advisornet Financial reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
Advisornet Financial sold 40 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $562.
Advisornet Financial first reported a position in Dr. Reddy's Laboratories in Q1 2022 and held it in 11 quarters.
Advisornet Financial's Dr. Reddy's Laboratories position peaked at $3K in Q2 2022.
249 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Advisornet Financial's 13F filing for Q1 2026, filed 17 Apr 2026.